JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vinegar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vinegar, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 161, Issue 2, 389-395, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


QUANTITATIVE STUDIES CONCERNING KAOLIN EDEMA FORMATION IN RATS

R. Vinegar 1

1 The Wellcome Research Laboratories, Burroughs Wellcome & Co. (U.S.A.) Inc., Tuckahoe, New York

Following a subplantar injection of 5.0 mg of kaolin in rats, the time curve of the developing edema volume is biphasic over the first 7 hr. There is a rapid rise initially which diminishes in 1 hr, and a second phase which accelerates sharply from the 4th through the 7th hr. A reduction of the dose of kaolin to 0.20 mg eliminated the second phase but did not change the first phase volume. Additional evidence for the independent character of the two phases was garnered from drug inhibition studies. Hydrocortisone and corticosterone were inactive against the first phase but very potent inhibitors of the second. The corticoid-insensitive phase represented approximately 40% of the 5-hr edema volume and, therefore, an inhibition of 60% was the maximum that could be achieved in this time interval with these hormones. Restricting the edema-inhibition studies with the adrenal corticoids solely to their effect on the second phase resulted in a more sensitive test and a steeper dose-response curve. Acetylsalicylic acid was equipotent against the two phases. Phenylbutazone was more potent against the second phase than against the first. In studies restricted to the second phase, the dose-response curve to phenylbutazone from 10 to 40 mg/kg was steep. At doses larger than 40 mg/kg the response was not dosedependent.

Submitted on December 7, 1967
Accepted on February 12, 1968




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Gao, S. C. Flores, J. A. Leff, S. K. Bose, and J. M. McCord
Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L917 - L925.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.